SPHK1 and atypical endometrial hyperplasia: As shown in Table 1, 69 cases (82.1%) of 86 patients with endometrial carcinoma were positive for SPHK1 and 2 cases (3.7%) of 54 patients with atypical hyperplasia of the endometrium were positive for SPHK1.